Marshall Wace, LLP Organogenesis Holdings Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 15,114 shares of ORGO stock, worth $42,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,114

Previous 822,154 98.16%

Holding current value

$42,319

Previous $3.36 Million 98.75%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $2.11 Million - $3.62 Million	-807,040 Reduced 98.16%	15,114 $42,000
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $713,366 - $1.52 Million	362,115 Added 78.71%	822,154 $3.36 Million
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $1.11 Million - $2.1 Million	-473,482 Reduced 50.72%	460,039 $1.46 Million
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $423,114 - $957,575	222,692 Added 31.33%	933,521 $3.1 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $1.34 Million - $2.08 Million	710,829 New	710,829 $1.51 Million

Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $91,791 - $187,968	29,233 New	29,233 $95,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $2.1 Million - $3.62 Million	-443,778 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $2.87 Million - $4.25 Million	443,778 New	443,778 $3.38 Million
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $470,113 - $703,606	-52,119 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $714,551 - $895,404	52,119 New	52,119 $742,000
Q2 2021 Aug 13, 2021	SELL	$14.92 - $23.23 $2.35 Million - $3.67 Million	-157,794 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.33 - $21.06 $514,793 - $1.48 Million	-70,231 Reduced 30.8%	157,794 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $827,730 - $1.72 Million	228,025 New	228,025 $1.72 Million
Q1 2020 May 15, 2020	SELL	$2.92 - $5.31 $109,260 - $198,689	-37,418 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $175,864 - $303,459	37,418 New	37,418 $180,000

Others Institutions Holding ORGO

# of Institutions

129

Shares Held

56.3M

Call Options Held

55.3K

Put Options Held

22.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $366M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Organogenesis Holdings Inc. Transaction History